The Metabolic Institute of America (TMIOA) was founded by Yehuda Handelsman, MD, in response to the growing global epidemic of obesity, diabetes, multiple metabolic disorders, and ASCVD. It is dedicated to education and clinical research of diabetes, obesity, lipid disorders, hypertension, and related disorders in order to prevent cardiovascular disease, heart failure and kidney disease. TMIOA’s mission is to advance the understanding, prevention, and management of metabolic diseases through the development and production of national and international conferences and congresses. TMIOA fosters, coordinates, and brings together diverse global experts and medical societies to promote educational initiatives while assisting in the development of multidisciplinary practice recommendations.
WHAT WE DO
Clinical Trial Research
The mission of TMIOA is to advance our understanding and management of metabolic diseases.
The organization focuses on pathophysiology and therapeutic modalities, as well as the education of health care professionals and the public. The institute initiates its own research and education activities, participates in ongoing initiatives, and provides management services to organizations and events.